Who are we

Print this page

Who are we?

pDNA_Logo.jpgThe Consortium groups are based in three of the leading UK universities. Prior to the formation of the Consortium each group had conducted at least one clinical trial for gene therapy. Therefore, our researchers have been at the forefront of this field for over 20 years.

Together against CF.

In 2001 the UK's three UK's three leading Cystic Fibrosis gene therapy groups joined together as one organisation, the UKCFGTC, to share expertise and funding

Aim.

The aim of this collaboration was to bring the three research groups together to focus on a single common goal of making gene therapy for CF a clinical reality.

Progress.

The Consortium is now the world's largest gene therapy group focused on a single disease, with a combined staff of over 50. We have recently completed one of the world’s largest gene therapy clinical trials for CF. This multi-dose trial will be the first ever opportunity to find out if our gene therapy can result in clinical benefit.

Consortium Members

  • University of Oxford: Gene Medicine Group
  • University of Edinburgh: Centre for Molecular Medicine and Roslin Institute
  • Imperial College London: Department of Gene Therapy, National Heart & Lung Institute

Saturday, August 2nd 2014

 

A frozen vial of GL67A (left) and a frozen vial of pGM169 plasmid DNA (right)

 

E.coli from a large scale industrial production of our clinical trial plasmid pGM169.